Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Salvato in:

Dettagli Bibliografici
Ente Autore:	Council for International Organizations of Medical Sciences (CIOMS)
Natura:	Libro
Lingua:	English
Pubblicazione:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Soggetti:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Accesso online:	Visit NHRC Library
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi

Martindale: the complete drug reference
di: Parfitt, Kathleen
Pubblicazione: (1999)

WHO drug information.
Pubblicazione: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Pubblicazione: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Pubblicazione: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Pubblicazione: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Pubblicazione: (2012)

USP DI. Approved drug products and legal requirements.
Pubblicazione: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
di: Andersson, Sarah
Pubblicazione: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Pubblicazione: (1997)

Pharmacology : a patient-centered nursing process approach /
di: Kee, Joyce LeFever, et al.

Drug calculations : ratio and proportion problems for clinical practice /
di: Seltzer, Meta Brown, et al.

Effective drug regulation a multicountry study /
di: Ratanawijitrasin, Sauwakon
Pubblicazione: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
di: DEVS Consult Nepal (P) Ltd.
Pubblicazione: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
di: Acharya,Kiran
Pubblicazione: (2018)

Regulatory Situation of Herbal Medicines
Pubblicazione: (1998)

A text book of pharmacognosy.
di: Raut, Bechan, et al.
Pubblicazione: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
di: Adhikari, SM, et al.
Pubblicazione: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Pubblicazione: (2012)

AHFS drug information 2000
di: Snow, Elaine, K
Pubblicazione: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Pubblicazione: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
di: Nepal Health Research Council (NHRC), et al.
Pubblicazione: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
di: Yadav, Raju
Pubblicazione: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Pubblicazione: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
di: Brody, Tom
Pubblicazione: (2016)

Evaluation of certain veterinary drug residues in food
Pubblicazione: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
di: Aryal, BK, et al.
Pubblicazione: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
di: Pande, Sarala
Pubblicazione: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
di: Adhikari, Shyam Mani
Pubblicazione: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
di: Adhikari, Shyam Mani, Dr.
Pubblicazione: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Pubblicazione: (1995)

Fundamentals of Clinical Trials /
di: Friedman, Lawrence M, et al.
Pubblicazione: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Pubblicazione: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Pubblicazione: (2000)

Drug policy in the Americas
di: Smith, Peter H.
Pubblicazione: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Pubblicazione: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Pubblicazione: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
di: Poudel, Krishna Prasad
Pubblicazione: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
di: Maskay, NM, et al.
Pubblicazione: (2016)